BRUKER CORP (BRKR) Fundamental Analysis & Valuation

NASDAQ:BRKR • US1167941087

Current stock price

37.98 USD
-0.27 (-0.71%)
At close:
38.0192 USD
+0.04 (+0.1%)
After Hours:

This BRKR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

4

1. BRKR Profitability Analysis

1.1 Basic Checks

  • BRKR had positive earnings in the past year.
  • In the past year BRKR had a positive cash flow from operations.
  • Of the past 5 years BRKR 4 years were profitable.
  • Each year in the past 5 years BRKR had a positive operating cash flow.
BRKR Yearly Net Income VS EBIT VS OCF VS FCFBRKR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • With a decent Return On Assets value of -0.36%, BRKR is doing good in the industry, outperforming 64.91% of the companies in the same industry.
  • The Return On Equity of BRKR (-0.92%) is better than 66.67% of its industry peers.
  • The Return On Invested Capital of BRKR (4.32%) is better than 71.93% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for BRKR is below the industry average of 11.38%.
Industry RankSector Rank
ROA -0.36%
ROE -0.92%
ROIC 4.32%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.91%
ROIC(5y)9.93%
BRKR Yearly ROA, ROE, ROICBRKR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • Looking at the Operating Margin, with a value of 7.90%, BRKR is in the better half of the industry, outperforming 64.91% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BRKR has declined.
  • Looking at the Gross Margin, with a value of 47.13%, BRKR is in line with its industry, outperforming 50.88% of the companies in the same industry.
  • BRKR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.9%
PM (TTM) N/A
GM 47.13%
OM growth 3Y-24.07%
OM growth 5Y-9.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.99%
GM growth 5Y-0.06%
BRKR Yearly Profit, Operating, Gross MarginsBRKR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

3

2. BRKR Health Analysis

2.1 Basic Checks

  • BRKR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • The number of shares outstanding for BRKR has been increased compared to 1 year ago.
  • BRKR has about the same amout of shares outstanding than it did 5 years ago.
  • BRKR has a better debt/assets ratio than last year.
BRKR Yearly Shares OutstandingBRKR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BRKR Yearly Total Debt VS Total AssetsBRKR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • BRKR has an Altman-Z score of 2.32. This is not the best score and indicates that BRKR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • BRKR has a Altman-Z score of 2.32. This is comparable to the rest of the industry: BRKR outperforms 57.89% of its industry peers.
  • BRKR has a debt to FCF ratio of 131.63. This is a negative value and a sign of low solvency as BRKR would need 131.63 years to pay back of all of its debts.
  • With a Debt to FCF ratio value of 131.63, BRKR perfoms like the industry average, outperforming 50.88% of the companies in the same industry.
  • A Debt/Equity ratio of 0.75 indicates that BRKR is somewhat dependend on debt financing.
  • The Debt to Equity ratio of BRKR (0.75) is worse than 73.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 131.63
Altman-Z 2.32
ROIC/WACC0.43
WACC10.17%
BRKR Yearly LT Debt VS Equity VS FCFBRKR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • BRKR has a Current Ratio of 1.73. This is a normal value and indicates that BRKR is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of BRKR (1.73) is worse than 75.44% of its industry peers.
  • A Quick Ratio of 0.86 indicates that BRKR may have some problems paying its short term obligations.
  • BRKR has a worse Quick ratio (0.86) than 87.72% of its industry peers.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 0.86
BRKR Yearly Current Assets VS Current LiabilitesBRKR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. BRKR Growth Analysis

3.1 Past

  • The earnings per share for BRKR have decreased strongly by -24.07% in the last year.
  • BRKR shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.27% yearly.
  • The Revenue has been growing slightly by 2.08% in the past year.
  • The Revenue has been growing by 11.57% on average over the past years. This is quite good.
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%

3.2 Future

  • The Earnings Per Share is expected to grow by 13.64% on average over the next years. This is quite good.
  • Based on estimates for the next years, BRKR will show a small growth in Revenue. The Revenue will grow by 4.37% on average per year.
EPS Next Y18.09%
EPS Next 2Y16.09%
EPS Next 3Y16.04%
EPS Next 5Y13.64%
Revenue Next Year4.67%
Revenue Next 2Y4.22%
Revenue Next 3Y4.43%
Revenue Next 5Y4.37%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BRKR Yearly Revenue VS EstimatesBRKR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
BRKR Yearly EPS VS EstimatesBRKR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

5

4. BRKR Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 20.75, BRKR is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Earnings ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 84.21% of the companies listed in the same industry.
  • BRKR's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.91.
  • The Price/Forward Earnings ratio is 17.57, which indicates a rather expensive current valuation of BRKR.
  • Based on the Price/Forward Earnings ratio, BRKR is valued cheaply inside the industry as 82.46% of the companies are valued more expensively.
  • BRKR's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.68.
Industry RankSector Rank
PE 20.75
Fwd PE 17.57
BRKR Price Earnings VS Forward Price EarningsBRKR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BRKR indicates a rather cheap valuation: BRKR is cheaper than 82.46% of the companies listed in the same industry.
  • BRKR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 407.14
EV/EBITDA 14.95
BRKR Per share dataBRKR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • A more expensive valuation may be justified as BRKR's earnings are expected to grow with 16.04% in the coming years.
PEG (NY)1.15
PEG (5Y)3.31
EPS Next 2Y16.09%
EPS Next 3Y16.04%

5

5. BRKR Dividend Analysis

5.1 Amount

  • BRKR has a yearly dividend return of 0.59%, which is pretty low.
  • The stock price of BRKR dropped by -30.26% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
  • BRKR's Dividend Yield is rather good when compared to the industry average which is at 0.12. BRKR pays more dividend than 89.47% of the companies in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.89, BRKR's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.59%

5.2 History

  • On average, the dividend of BRKR grows each year by 6.15%, which is quite nice.
  • BRKR has paid a dividend for at least 10 years, which is a reliable track record.
  • As BRKR did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)6.15%
Div Incr Years0
Div Non Decr Years9
BRKR Yearly Dividends per shareBRKR Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.05 0.1 0.15

5.3 Sustainability

  • The earnings of BRKR are negative and hence is the payout ratio. BRKR will probably not be able to sustain this dividend level.
  • BRKR's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-146.22%
EPS Next 2Y16.09%
EPS Next 3Y16.04%
BRKR Yearly Income VS Free CF VS DividendBRKR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

BRKR Fundamentals: All Metrics, Ratios and Statistics

BRUKER CORP

NASDAQ:BRKR (4/9/2026, 8:14:44 PM)

After market: 38.0192 +0.04 (+0.1%)

37.98

-0.27 (-0.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-12
Earnings (Next)05-05
Inst Owners91.17%
Inst Owner Change0%
Ins Owners26.98%
Ins Owner Change0.1%
Market Cap5.78B
Revenue(TTM)3.44B
Net Income(TTM)-22.50M
Analysts79.09
Price Target49.93 (31.46%)
Short Float %10.35%
Short Ratio4.53
Dividend
Industry RankSector Rank
Dividend Yield 0.59%
Yearly Dividend0.22
Dividend Growth(5Y)6.15%
DP-146.22%
Div Incr Years0
Div Non Decr Years9
Ex-Date03-23
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.4%
Min EPS beat(2)-10.9%
Max EPS beat(2)31.69%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)1.39%
EPS beat(12)8
Avg EPS beat(12)4.7%
EPS beat(16)11
Avg EPS beat(16)5.48%
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)-0.29%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)1
Avg Revenue beat(8)-1.04%
Revenue beat(12)5
Avg Revenue beat(12)0.47%
Revenue beat(16)8
Avg Revenue beat(16)0.64%
PT rev (1m)0%
PT rev (3m)-3.34%
EPS NQ rev (1m)1.22%
EPS NQ rev (3m)-42.9%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.86%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)0%
Revenue NY rev (3m)3.22%
Valuation
Industry RankSector Rank
PE 20.75
Fwd PE 17.57
P/S 1.68
P/FCF 407.14
P/OCF 43.02
P/B 2.35
P/tB 628.4
EV/EBITDA 14.95
EPS(TTM)1.83
EY4.82%
EPS(NY)2.16
Fwd EY5.69%
FCF(TTM)0.09
FCFY0.25%
OCF(TTM)0.88
OCFY2.32%
SpS22.58
BVpS16.14
TBVpS0.06
PEG (NY)1.15
PEG (5Y)3.31
Graham Number25.78
Profitability
Industry RankSector Rank
ROA -0.36%
ROE -0.92%
ROCE 5.47%
ROIC 4.32%
ROICexc 4.6%
ROICexgc 9.68%
OM 7.9%
PM (TTM) N/A
GM 47.13%
FCFM 0.41%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.91%
ROIC(5y)9.93%
ROICexc(3y)8.9%
ROICexc(5y)13.25%
ROICexgc(3y)16.34%
ROICexgc(5y)22.09%
ROCE(3y)10.01%
ROCE(5y)12.56%
ROICexgc growth 3Y-29.19%
ROICexgc growth 5Y-14.74%
ROICexc growth 3Y-36.05%
ROICexc growth 5Y-19.66%
OM growth 3Y-24.07%
OM growth 5Y-9.96%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.99%
GM growth 5Y-0.06%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 131.63
Debt/EBITDA 3.77
Cap/Depr 54.56%
Cap/Sales 3.5%
Interest Coverage 3.83
Cash Conversion 27.32%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 0.86
Altman-Z 2.32
F-Score4
WACC10.17%
ROIC/WACC0.43
Cap/Depr(3y)70.11%
Cap/Depr(5y)91.82%
Cap/Sales(3y)3.51%
Cap/Sales(5y)3.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
EPS Next Y18.09%
EPS Next 2Y16.09%
EPS Next 3Y16.04%
EPS Next 5Y13.64%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%
Revenue Next Year4.67%
Revenue Next 2Y4.22%
Revenue Next 3Y4.43%
Revenue Next 5Y4.37%
EBIT growth 1Y-29.82%
EBIT growth 3Y-15.92%
EBIT growth 5Y0.46%
EBIT Next Year53.54%
EBIT Next 3Y21.21%
EBIT Next 5Y17.15%
FCF growth 1Y-89.56%
FCF growth 3Y-53.93%
FCF growth 5Y-42.95%
OCF growth 1Y-46.52%
OCF growth 3Y-21.17%
OCF growth 5Y-16.56%

BRUKER CORP / BRKR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for BRUKER CORP?

ChartMill assigns a fundamental rating of 4 / 10 to BRKR.


What is the valuation status for BRKR stock?

ChartMill assigns a valuation rating of 5 / 10 to BRUKER CORP (BRKR). This can be considered as Fairly Valued.


What is the profitability of BRKR stock?

BRUKER CORP (BRKR) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for BRKR stock?

The Price/Earnings (PE) ratio for BRUKER CORP (BRKR) is 20.75 and the Price/Book (PB) ratio is 2.35.


Can you provide the dividend sustainability for BRKR stock?

The dividend rating of BRUKER CORP (BRKR) is 5 / 10 and the dividend payout ratio is -146.22%.